GALPHARM INTERNATIONAL LIMITED
Get an alert when GALPHARM INTERNATIONAL LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£287K
-11.1% lowest in 3 filed years
Net assets
-£181K
-887% lowest in 3 filed years
Employees
—
Average over period
Profit before tax
-£70K
-101.2% lowest in 3 filed years
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
Accounts not prepared on a going-concern basis
The financial statements therefore have not been prepared on a going concern basis. Instead, they have been prepared on a break-up basis reflecting the imminent liquidation and closure of the company.
-
Going-concern uncertainty disclosed
-
Negative shareholders' funds
Net assets
3-year trend · vs Consumer Discretionary median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | £123,079,000 | £57,374,000 | £0 | -100% | |
| Operating profit | £5,756,000 | £4,278,000 | £15,000 | -99.6% | |
| Profit before tax | £5,447,000 | £5,664,000 | -£70,000 | -101.2% | |
| Net profit | £4,152,000 | £4,388,000 | -£204,000 | -104.6% | |
| Cash | £520,000 | £323,000 | £287,000 | -11.1% | |
| Total assets less current liabilities | £34,128,000 | £23,000 | -£181,000 | -887% | |
| Net assets | £34,128,000 | £23,000 | -£181,000 | -887% | |
| Equity | £34,128,000 | £23,000 | -£181,000 | -887% | |
| Average employees | 85 | 35 | — | — | |
| Wages | £3,322,000 | £1,506,000 | — | — | |
| Directors' remuneration | £351,000 | £341,000 | £3,000 | -99.1% |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Operating margin | 4.7% | 7.5% | — | |
| Net margin | 3.4% | 7.6% | — | |
| Return on capital employed | 16.9% | — | — | |
| Current ratio | 2.38x | 1.08x | 0.61x | |
| Interest cover | 6.30x | 12.51x | 0.16x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 1 time since incorporation
- GALPHARM INTERNATIONAL LIMITED 1995-12-22 → present
- GAL PHARM INTERNATIONAL LIMITED 1981-02-24 → 1995-12-22
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Abridged
- Yes — abridged accounts (limited disclosure)
- Audit opinion
- Unaudited (audit-exempt)
- Going concern
- Not a going concern (break-up basis)
“The financial statements therefore have not been prepared on a going concern basis. Instead, they have been prepared on a break-up basis reflecting the imminent liquidation and closure of the company.”
Significant events
- “On 3 June 2024, all trade and assets were transferred to Omega Pharma Limited, a company within the same group. Following this transfer, the company ceased trading and, at the balance sheet date, was not carrying on any trading activities. The company is currently undergoing a process to conclude its affairs, and the directors expect that it will be placed into liquidation with 12 months of signing these statutory accounts.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 21 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| LORDEN, Bradley | Secretary | 2025-02-21 | — | — |
| DOHERTY, Sarah Jane | Director | 2025-02-03 | Feb 1984 | British |
| RUDD, Christopher Allan | Director | 2018-04-03 | Sep 1980 | British |
Show 21 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| CORCORAN, Annette | Secretary | 2017-05-25 | 2025-02-21 |
| HEWERDINE, Mark | Secretary | 1998-08-01 | 2008-01-09 |
| HOYLE, Melvyn | Secretary | 1996-03-31 | 1998-07-31 |
| KAVANAGH, Niall Patrick | Secretary | 2014-05-27 | 2017-05-25 |
| LESLIE, Craig Andrew | Secretary | 1995-01-11 | 1996-03-31 |
| LESLIE, Graham Andrew, Dr | Secretary | — | 1995-01-11 |
| TUCKER, Michael Andrew | Secretary | 2008-01-09 | 2014-05-27 |
| BRASS, Andrew Ronald | Director | — | 1993-05-04 |
| COX, Peter Noel Miller | Director | 1997-04-11 | 1999-12-31 |
| DOSE, Sheenagh | Director | 2018-04-03 | 2018-07-11 |
| HOLME, Richard | Director | 2023-01-03 | 2024-03-31 |
| HOWARD, Russell Peter | Director | 2008-01-09 | 2016-02-05 |
| LESLIE, Anne Rachel | Director | — | 1995-06-19 |
| LESLIE, Craig Andrew | Director | 1992-09-01 | 2008-01-09 |
| LESLIE, Graham Andrew, Dr | Director | — | 2008-01-09 |
| LISTER, Neil Thomas | Director | 2016-02-05 | 2023-01-03 |
| MILLS, Stuart Charles | Director | 2024-03-31 | 2025-08-31 |
| O'SULLIVAN, Patrick Michael | Director | 2014-03-18 | 2018-04-03 |
| RIVERS, Dominic James | Director | 2018-04-03 | 2025-02-03 |
| THOMPSON, Philip | Director | 2017-09-01 | 2018-04-03 |
| TUCKER, Michael Andrew | Director | 2008-01-09 | 2016-10-31 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Galpharm Healthcare Limited | Corporate entity | Shares 75–100% | 2016-04-06 | Active |
Filing timeline
Last 20 of 164 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-06-24 | AA | accounts | Accounts with accounts type full | |
| 2026-04-24 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2026-04-15 | RP01AP01 | officers | Replacement filing of director appointment with name | |
| 2026-01-22 | RP01AP01 | officers | Replacement filing of director appointment with name | |
| 2025-10-09 | AA | accounts | Accounts with accounts type full | |
| 2025-09-02 | TM01 | officers | Termination director company with name termination date | |
| 2025-05-15 | CH01 | officers | Change person director company with change date | |
| 2025-04-03 | TM01 | officers | Termination director company with name termination date | |
| 2025-03-23 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-03-07 | AP03 | officers | Appoint person secretary company with name date | |
| 2025-03-07 | TM02 | officers | Termination secretary company with name termination date | |
| 2025-02-21 | AP01 | officers | Appoint person director company with name date | |
| 2024-09-11 | AA | accounts | Accounts with accounts type full | |
| 2024-04-15 | AP01 | officers | Appoint person director company with name date | |
| 2024-04-12 | TM01 | officers | Termination director company with name termination date | |
| 2024-03-25 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-05-24 | AA | accounts | Accounts with accounts type full | |
| 2023-03-27 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-01-10 | AP01 | officers | Appoint person director company with name date | |
| 2023-01-10 | TM01 | officers | Termination director company with name termination date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 6
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 1
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.